Piper Jaffray analyst Edward Tenthoff, a global-conference veteran, made his inaugural appearance at the Vatican at the second International Vatican Adult Stem Cell Conference in April.
Tenthoff was one of 350 scientists, physicians, religious leaders, industry representatives and others to raise awareness of the therapeutic potential of adult stem cells.
The Catholic Church supports research on adult stem cells as an ethical and moral alternative to research on embryonic stem cells.
Tenthoff, a senior research analyst who works out of Piper's New York office, said the event cemented his view that "a revolution is quietly taking place in stem-cell medicine."
"This is such a unique message from the church and such a progressive message to be supporting adult stem cell science and medicine," said Tenthoff, who was raised Catholic. "I said I want to help get that message out."
Tenthoff got the conference invite through Dr. Robin Smith, CEO of New York-based NeoStem, an emerging biotechnology company and one of the event sponsors. Tenthoff moderated a keynote panel on regenerative medicine. The conference included topics on medicine, regulation, politics and ethics.
"I don't think the public, or even investors … quite realize how much progress and how many successes are actually taking place in this field." Tenthoff said. "This is fundamentally going to change the way medicine is practiced. When you cut yourself, it's stem cells and regenerative cells that heal you. So adults have stem cells in their body. We are talking cures here."
There is enough interest in the field that Piper co-sponsored the inaugural RegenMed Investor Day in New York on April 17, in which Tenthoff also participated. Tenthoff sees investment opportunities in some wound-care companies and emerging companies focused on heart disease.